Greentown Labs
Debt Financing in 2024
Established in 2011, Greentown Labs offers shared workspace, prototyping facilities, and event spaces for businesses focused on climate technology, clean energy, and environmental industries. Its mission is to foster a vibrant community of entrepreneurs by providing access to resources, funding, and collaborative spaces.
Greentown Labs
Grant in 2024
Established in 2011, Greentown Labs offers shared workspace, prototyping facilities, and event spaces for businesses focused on climate technology, clean energy, and environmental industries. Its mission is to foster a vibrant community of entrepreneurs by providing access to resources, funding, and collaborative spaces.
Mallard Bay operates an online marketplace and booking platform for hunting and fishing adventures. It connects sportsmen with safe, reliable hunting and fishing spots and helps users discover, compare, and book guided trips. The service includes secure payment processing and back-office tools that help guides showcase trips, manage bookings, and handle payments, enabling providers to run their operations efficiently and clients to plan outdoor experiences with ease.
TransCrypts
Seed Round in 2021
TransCrypts automates issuance of employment and income verification documents for HR departments using blockchain technology. This streamlines compliance processes, saving time and resources, while empowering employees to control how their work information is shared.
RANDIAN
Seed Round in 2019
RANDIAN offers a patented interactive platform that combines video content with e-commerce. It enables users to shop for clothing seen on characters in shows while watching, driving direct sales for brands and increasing viewer engagement.
OncoResponse
Series B in 2018
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.
Medical Magnesium
Seed Round in 2017
Medical Magnesium specializes in developing metallic bioabsorbable implants for orthopedic and trauma surgery. Their innovative magnesium-based solutions are mechanically stable during healing but physiologically degrade afterwards, eliminating the need for metal removal surgeries.
OncoResponse
Series A in 2016
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.